Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitality: Testosterone for hypogonadism in lymphoma survivors
NCT04492553Phase 2Completed
- Start
- Apr 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AndroForte in Hypogonadism. Started Apr 2021; status: completed.
02
Drugs
AndroForte
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT04492553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04492553.